for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

EIS Eczacibs Ilc Sn Fnsl Ytrmlr Sny Tcrt

ECILC.IS

Latest Trade

2.85TRY

Change

0.06(+2.15%)

Volume

4,788,146

Today's Range

2.76

 - 

2.87

52 Week Range

2.14

 - 

3.75

As of on the Istanbul Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
2.79
Open
2.80
Volume
4,788,146
3M AVG Volume
61.68
Today's High
2.87
Today's Low
2.76
52 Week High
3.75
52 Week Low
2.14
Shares Out (MIL)
685.26
Market Cap (MIL)
1,911.88
Forward P/E
--
Dividend (Yield %)
7.17

Latest Developments

More

EIS Eczacibasi Q2 Net Profit Decreases To 109.9 Million Lira YoY

Eis Eczacibasi Ilac Q1 Net Result Turns To Loss Of 9.0 Million Lira

Eis Eczacibasi Ilac Appoints Canan Bademlioglu As CEO

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About EIS Eczacibs Ilc Sn Fnsl Ytrmlr Sny Tcrt

EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS, formerly known as Eczacibasi Ilac Sanayi ve Ticaret A.S., (EIS) is a Turkey-based company active in the pharmaceutical industry through its subsidiaries, affiliates and joint ventures. Its product portfolio consists of drugs for human health, veterinary drugs and personal care products, such as body and facial creams, hair gels, deodorants and various other products. The Company is also engaged in real estate development and construction through its subsidiary, Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., formerly known as Eczacibasi Insaat ve Ticaret A.S. Its subsidiaries also include Eczacibasi Ilac Ticaret A.S. (EIT), EHP Eczacibasi Health Care Products Joint Stock Co. (EHP), and Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., among others. EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a member of Eczacibasi Group of Companies.

Industry

Major Drugs

Contact Info

Buyukdere Cad. Ali Kaya Sok. No:5 Levent

+90.212.3508000

http://www.eis.com.tr

Executive Leadership

Ferit Bulent Eczacibasi

Non-Executive Chairman of the Board of Directors

Canan Bademlioglu

General Manager

Rahmi Faruk Eczacibasi

Non-Executive Vice Chairman of the Board of Directors

Bulent Avci

Finance Director

Ayse Deniz Ozger

Business Development Consultant

Key Stats

Price To Earnings (TTM)
11.39
Price To Sales (TTM)
2.60
Price To Book (MRQ)
0.49
Price To Cash Flow (TTM)
10.75
Total Debt To Equity (MRQ)
3.08
LT Debt To Equity (MRQ)
0.90
Return on Investment (TTM)
4.30
Return on Equity (TTM)
4.00

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up